FAHD2CP

Across TCGA pan-cancer cohorts, FAHD2CP RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated FAHD2CP data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher FAHD2CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAHD2CP expression acts as an unfavorable survival marker, although some lineages such as LUAD and PAAD show a favorable association.

KIRC, KIRP, and LIHC are the cancer types where FAHD2CP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.469	0.716	<.001	126	view →
KIRP	OS	Quartile	II,III,IV	0.241	0.625	.001	67	view →
LIHC	DFS	Quartile	All	0.352	0.530	.001	55	view →
LUAD	OS	Quartile	All	0.871	0.653	.001	47	view →
LGG	DFS	Median	All	0.658	0.804	<.001	39	view →
UCS	OS	Median	IV	0.302	0.817	.002	36	view →
ACC	DFS	Tertile	All	0.439	0.781	.001	29	view →
PAAD	OS	Quartile	All	0.628	0.326	.001	28	view →
LAML	DFS	Median	All	0.478	0.652	.003	26	view →
COAD	OS	Tertile	All	0.511	0.729	.006	23	view →
THCA	OS	Quartile	III,IV	0.755	1.000	.005	23	view →
SKCM	DFS	Tertile	III,IV	0.593	0.382	.002	20	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

FAHD2CP–KIRC (OS)

Open the KIRC breakdown →